Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.
Saved in:
| Title: | Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response. |
|---|---|
| Authors: | Cui X; Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, United States. Electronic address: xinle.cui@usuhs.edu., Cao Z; Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, United States., Wang S; Department of Biochemistry, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, United States., Lee RB; Department of Pediatrics, Virginia Commonwealth University, Richmond, VA 23298, United States., Wang X; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Murata H; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Adler SP; CMV Research Foundation, Richmond VA 23229, United States., McVoy MA; Department of Pediatrics, Virginia Commonwealth University, Richmond, VA 23298, United States., Snapper CM; Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, United States. |
| Source: | Vaccine [Vaccine] 2018 Sep 05; Vol. 36 (37), pp. 5580-5590. Date of Electronic Publication: 2018 Aug 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
